ImmunityBio (IBRX) Debt Ratio (2014 - 2026)

ImmunityBio (IBRX) has reported Debt Ratio for 12 consecutive years, with 0.63 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt Ratio fell 35.9% year-over-year to 0.63; the TTM figure through Mar 2026 stood at 0.63 (down 35.9% YoY), while the FY2025 annual figure was 0.65, down 12.92% from the prior year.
• Debt Ratio eased to 0.63 in Q1 2026 per IBRX's latest filing, from 0.65 in the prior quarter.
• Across five years, Debt Ratio topped out at 1.11 in Q3 2023 and bottomed at 0.24 in Q2 2024.
• Historically, Debt Ratio has averaged 0.69 across 5 years, with a median of 0.72 in 2023.
• Annual changes were most pronounced in 2024 — Debt Ratio slumped 72.54% — and 2025, when it surged 211.84%.
• ImmunityBio's Debt Ratio stood at 1.06 in 2022, then slumped by 70.87% to 0.31 in 2023, then surged by 141.07% to 0.74 in 2024, then slipped by 12.92% to 0.65 in 2025, then fell by 3.33% to 0.63 in 2026.
• Business Quant data shows IBRX's Debt Ratio at 0.63 in Q1 2026, 0.65 in Q4 2025, and 0.61 in Q3 2025.